|
Variables
|
Total (N = 36)
|
SLT-B group (N = 15)
|
DLT group (N = 21)
|
P value*
|
|---|
|
Age (years)
|
43.7 ± 10.6
|
45.2 ± 8.9
|
42.6 ± 11.7
|
0.469
|
|
Sex
| | | |
0.681
|
|
Male
|
23 (63.9%)
|
9
|
14
| |
|
Female
|
13 (36.1%)
|
6
|
7
| |
|
Tumour location
| | | |
0.803
|
|
Upper
|
8 (22.2%)
|
4
|
4
| |
|
Middle
|
19 (52.8%)
|
7
|
12
| |
|
Lower
|
9 (25%)
|
4
|
5
| |
|
Presenting symptoms
| | | |
0.923
|
|
Asymptomatic
|
20 (55.6%)
|
8
|
12
| |
|
Dysphagia
|
10 (27.8%)
|
5
|
5
| |
|
Regurgitation
|
3 (8.3%)
|
1
|
2
| |
|
Chest discomfort
|
3 (8.3%)
|
1
|
2
| |
|
Time to surgery (months)
|
2 (2, 7.5)
|
2 (2, 3)
|
3 (1.5, 9.5)
|
0.334
|
|
Tumour size (cm)
|
|
All patients
|
4.3 ± 2.0
|
5.4 ± 2.1
|
3.5 ± 1.4
|
0.004
|
|
Patients without symptoms
|
3.7 ± 1.7
| | |
0.035**
|
|
Patients with symptoms
|
5.1 ± 2.0
| | | |
- *Comparison between the SLT-B group and DLT group, **comparison between patients without symptoms and patients with symptoms
